America Great Health 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
OTC.Pink
America Great Health's Q1 2026 filing reveals a significant decrease in sales and continued operational losses, raising substantial doubt about its ability to continue as a going concern.
OTC.Pink
America Great Health's Q3 2025 report shows increased sales due to new product launches, but the company still faces substantial doubt about its ability to continue as a going concern due to recurring net losses and a significant shareholders' deficit.
OTC.Pink
America Great Health's Q2 2025 report shows increased sales due to new product launches, but the company still faces net losses and substantial doubt about its ability to continue as a going concern.
OTC.Pink
America Great Health's Q1 2025 shows increased sales due to new product launches, but the company still faces a significant shareholders' deficit and going concern uncertainties.
OTC.Pink
America Great Health saw a significant increase in sales during the third quarter of 2024, but ongoing losses and a substantial shareholders' deficit raise concerns about the company's ability to continue as a going concern.
OTC.Pink
10-Q: America Great Health Reports Increased Sales but Continues to Face Losses in Latest Quarterly Filing
America Great Health's latest quarterly report shows increased sales driven by new products, but the company continues to operate at a loss and faces going concern challenges.
OTC.Pink
America Great Health has filed an amended quarterly report on Form 10-Q/A for the period ended September 30, 2023, to include updated certifications and explanations regarding its financial results.